Taiwan
How Our Microbiomes Are Connected to Irritable Bowel Syndromes, Cancer and Autism: Highlights from the 6th Asia Microbiome Conference
2022-02-14
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17Partner
After Winning Approval for Its Painkiller in Thailand, Taiwan’s Lumosa Aims for Korea Nod
2022-01-02
Can Regulations Measure up to the Progress of Precision Medicine in Taiwan? – An Interview With Dr. Johnsee Lee
2021-10-30
How Can Taiwan’s Biopharma Seize the Next Global Business Opportunity? – An Interview with Dr. Jerome Shen
2021-10-17
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115